Medtronic announces intent to separate Diabetes business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Evercore ISI Removes Medtronic, Inc. (MDT) from TAP List
May 21, 2025 4:52 PM EDTEvercore ISI analyst Vijay Kumar reiterated an Outperform rating and $103.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Heading into earnings, we had TAP (tactical, actionable, positioning) calls on A, DHR, ENOV, MDT, SYK, TMO, & RVTY (previous tap note... More
Medtronic, Inc. (MDT) PT Lowered to $98 at Citi
May 21, 2025 2:08 PM EDTCiti analyst Joanna Wuensch lowered the price target on Medtronic, Inc. (NYSE: MDT) to $98.00 (from $103.00) while maintaining a Buy rating.
The analyst comments "This was a quarterly report where many things seemed to go right for Medtronic: 1) FY4Q25 revenue $8.93B (up 5.4% y/y... More
